These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7428086)

  • 21. Respiratory distress caused by a unilateral hydrothorax as only manifestation of ovarian hyperstimulation syndrome.
    Qublan HS; Barakat M
    J Obstet Gynaecol; 2006 Aug; 26(6):585-6. PubMed ID: 17000522
    [No Abstract]   [Full Text] [Related]  

  • 22. Pulmonary oedema in the ovarian hyperstimulation syndrome.
    Shulman DL; Sherer D; Beilin B
    N Z Med J; 1988 Oct; 101(855):643-4. PubMed ID: 3173880
    [No Abstract]   [Full Text] [Related]  

  • 23. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM; Tomazevic T
    J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is 250 microg rHCG always better and safer than 500 microg rHCG?
    Chan CC; Ng EH
    Hum Reprod; 2006 Feb; 21(2):569-70. PubMed ID: 16423839
    [No Abstract]   [Full Text] [Related]  

  • 26. [Echo-structural variants of the ovarian hyperstimulation syndrome].
    Giorlandino C; Vizzone A; Gentili P; Nanni C; Calugi A; Santini E; Spina M
    Ann Ostet Ginecol Med Perinat; 1987; 108(3):172-8. PubMed ID: 3318625
    [No Abstract]   [Full Text] [Related]  

  • 27. Oocytes in the empty follicle: a controversial syndrome.
    Aktas M; Beckers NG; van Inzen WG; Verhoeff A; de Jong D
    Fertil Steril; 2005 Dec; 84(6):1643-8. PubMed ID: 16359958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro oocyte maturation for safer treatment of infertility. The risk of ovarian overstimulation syndrome is minimized].
    Hreinsson J; Fridström M
    Lakartidningen; 2004 Nov; 101(46):3665-8, 3671. PubMed ID: 15586490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An unrecognized etiology of pleurisy: ovarian hyperstimulation syndrome (report of a case and physiopathologic discussion)].
    M'Raihi ML; Ladjimi S; Djemel A; Zegaya M
    Rev Pneumol Clin; 1989; 45(1):43-4. PubMed ID: 2740706
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic dysfunction associated with moderate ovarian hyperstimulation syndrome. A case report.
    Elter K; Scoccia B; Nelson LR
    J Reprod Med; 2001 Aug; 46(8):765-8. PubMed ID: 11547654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships in medicine--causal vs. casual.
    McDonough PG
    Fertil Steril; 1999 Jul; 72(1):190. PubMed ID: 10428181
    [No Abstract]   [Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe OHSS: patients should be allowed to weigh the morbidity of OHSS against the benefits of parenthood.
    Mathur RS; Jenkins JM
    Hum Reprod; 1999 Sep; 14(9):2183-5. PubMed ID: 10469677
    [No Abstract]   [Full Text] [Related]  

  • 35. Ovarian hyperstimulation syndrome.
    Sadan O; Blankstein J; Bloom S; Frankel Y; Menczer J; Mashiach S
    S Afr Med J; 1986 May; 69(11):668a-668b. PubMed ID: 3085240
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of oral melatonin on natural and gonadotropin-induced ovarian function in the domestic cat.
    Graham LH; Swanson WF; Wildt DE; Brown JL
    Theriogenology; 2004 Apr; 61(6):1061-76. PubMed ID: 15036995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence of both serious and minor complications in young women undergoing oocyte donation.
    Maxwell KN; Cholst IN; Rosenwaks Z
    Fertil Steril; 2008 Dec; 90(6):2165-71. PubMed ID: 18249368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The empty follicle syndrome.
    Ng SP; Jamil MA; Nurshaireen A; Zainul MR
    Med J Malaysia; 2006 Oct; 61(4):499-500. PubMed ID: 17243533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pentoxifylline in the prevention of ovarian hyperstimulation syndrome in a rabbit model.
    Serin IS; Ozçelik B; Bekyurek T; Ozturk F; Koc N; Sahin Y
    Gynecol Endocrinol; 2002 Oct; 16(5):355-9. PubMed ID: 12587528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian hemorrhages induced in immature mice with human placental gonadotropin.
    Koide SS
    Experientia; 1972 Feb; 28(2):199-200. PubMed ID: 5020358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.